Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: The identification of predictive parameters of response to radioligand therapy (RLT) in NET patients is essential in order to avoid futile therapy toxicities. The relation between the tumor absorbed dose and therapy response has so far not been established.
Conference:
Presenting Author: Durmo R
Introduction: Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE is a targeted radionuclide treatment for patients with neuroendocrine tumors (NET).
Conference:
Presenting Author: Duan H
Authors: Duan H, Song H, Ferri V, Fisher G, Shaheen S,
Keywords: PRRT, NET, Dotatate, PET, early response, Pseudo-progression,
Introduction: .
Conference:
Presenting Author:
Authors: Scalorbi F, Calareso G, Garanzini E, Argiroffi G, Fuoco V,
Keywords: gep-net, prrt, tgr, progression, predictive model,
Introduction: Early evaluation by PET/CT during therapy has an important predictive value of the final response in some tumors (e.g. lymphomas).
Conference: 18th Annual ENETS Concerence (2021)
Presenting Author:
Authors: Durmo R, Cervati V, Finocchiaro D, Filice A, Casali M,
Introduction: PRRT response assessment is performed using RECIST, yet functional assessment using 68Ga-DOTATATE PET/CT and plasma CgA might give additional information about prediction of overall survival (OS).
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Huizing D, Aalbersberg E, Versleijen M, Tesselaar M, Walraven I,
Keywords: PRRT, RECIST, 68Ga-DOTATATE PET/CT, response,